KR100418319B1 - 치료 효과를 갖는 젤라틴성 신체 보호 제품 및 이의 제조방법 - Google Patents
치료 효과를 갖는 젤라틴성 신체 보호 제품 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100418319B1 KR100418319B1 KR10-2001-7002563A KR20017002563A KR100418319B1 KR 100418319 B1 KR100418319 B1 KR 100418319B1 KR 20017002563 A KR20017002563 A KR 20017002563A KR 100418319 B1 KR100418319 B1 KR 100418319B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- oil
- group
- mixtures
- gelatinous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 13
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000003921 oil Substances 0.000 claims abstract description 36
- 235000019198 oils Nutrition 0.000 claims abstract description 36
- -1 jojoba oil Substances 0.000 claims abstract description 14
- 239000000828 canola oil Substances 0.000 claims abstract description 7
- 235000019519 canola oil Nutrition 0.000 claims abstract description 7
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 7
- 229920002743 polystyrene-poly(ethylene-ethylene/propylene) block-polystyrene Polymers 0.000 claims abstract description 7
- 239000008169 grapeseed oil Substances 0.000 claims abstract description 6
- 229920002742 polystyrene-block-poly(ethylene/propylene) -block-polystyrene Polymers 0.000 claims abstract description 6
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 claims abstract description 6
- 241001116389 Aloe Species 0.000 claims abstract description 5
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 5
- 235000021302 avocado oil Nutrition 0.000 claims abstract description 5
- 239000008163 avocado oil Substances 0.000 claims abstract description 5
- 229940106189 ceramide Drugs 0.000 claims abstract description 5
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 5
- 239000011719 vitamin A Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 66
- 239000013543 active substance Substances 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 15
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000002759 woven fabric Substances 0.000 claims description 10
- 239000012213 gelatinous substance Substances 0.000 claims description 8
- 239000000123 paper Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 229920000178 Acrylic resin Polymers 0.000 claims description 4
- 239000004925 Acrylic resin Substances 0.000 claims description 4
- 235000011777 Corchorus aestuans Nutrition 0.000 claims description 4
- 235000010862 Corchorus capsularis Nutrition 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- 210000003423 ankle Anatomy 0.000 claims description 4
- 210000000085 cashmere Anatomy 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 210000002268 wool Anatomy 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 239000003518 caustics Substances 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 210000003127 knee Anatomy 0.000 claims description 3
- 230000035515 penetration Effects 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 229920002994 synthetic fiber Polymers 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 150000002193 fatty amides Chemical class 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 3
- 240000000491 Corchorus aestuans Species 0.000 claims 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 3
- 229920000297 Rayon Polymers 0.000 claims 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 3
- 239000002964 rayon Substances 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- 229940035674 anesthetics Drugs 0.000 claims 2
- 239000003193 general anesthetic agent Substances 0.000 claims 2
- 239000005445 natural material Substances 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 238000004581 coalescence Methods 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 235000011837 pasties Nutrition 0.000 claims 1
- 230000001012 protector Effects 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 abstract description 14
- 229920001400 block copolymer Polymers 0.000 abstract description 11
- 239000011782 vitamin Substances 0.000 abstract description 9
- 235000013343 vitamin Nutrition 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 9
- 229930003231 vitamin Natural products 0.000 abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 6
- 150000001783 ceramides Chemical class 0.000 abstract description 2
- 229920001169 thermoplastic Polymers 0.000 abstract description 2
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 2
- 239000012815 thermoplastic material Substances 0.000 abstract 2
- 229920001971 elastomer Polymers 0.000 description 12
- 239000000806 elastomer Substances 0.000 description 12
- 230000000996 additive effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 210000000707 wrist Anatomy 0.000 description 6
- 229920001083 polybutene Polymers 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UAUDZVJPLUQNMU-UHFFFAOYSA-N Erucasaeureamid Natural products CCCCCCCCC=CCCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229960003742 phenol Drugs 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940037312 stearamide Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920000428 triblock copolymer Polymers 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 206010006585 Bunion Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 240000004792 Corchorus capsularis Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- ORAWFNKFUWGRJG-UHFFFAOYSA-N Docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(N)=O ORAWFNKFUWGRJG-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 229920002633 Kraton (polymer) Polymers 0.000 description 1
- ZFOMKMMPBOQKMC-KXUCPTDWSA-N L-pyrrolysine Chemical compound C[C@@H]1CC=N[C@H]1C(=O)NCCCC[C@H]([NH3+])C([O-])=O ZFOMKMMPBOQKMC-KXUCPTDWSA-N 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical group C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 description 1
- SBNKFTQSBPKMBZ-UHFFFAOYSA-N ethenzamide Chemical compound CCOC1=CC=CC=C1C(N)=O SBNKFTQSBPKMBZ-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DJWFNQUDPJTSAD-UHFFFAOYSA-N n-octadecyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCCNC(=O)CCCCCCCCCCCCCCCCC DJWFNQUDPJTSAD-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960001807 prilocaine Drugs 0.000 description 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 238000010057 rubber processing Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/10—Wearable devices, e.g. garments, glasses or masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Gloves (AREA)
- Cosmetics (AREA)
- Socks And Pantyhose (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
Abstract
Description
Claims (52)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 기판(a),기판에 친밀하게 접착되어 있는 블럭 중합체를 포함하는 젤라틴성 물질(b),젤라틴성 물질 속에 혼입되어 있으며 비타민 A, B12, C, D, E 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 제1 치료 활성제(c) 및젤라틴성 물질 속에 혼입되어 있으며 포도씨 오일, 아보카도 오일, 호호바 오일, 카놀라 오일, 세라마이드, 알로에, 올리브 오일 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 천연 오일인 제2 치료 활성제(d)를 포함하는, 신체 보호 제품.
- 제31항에 있어서, 젤라틴성 물질이 SEBS, SEPS, SEEPS 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 신체 보호 제품.
- 제31항에 있어서, 기판이 직포, 종이, 중합체성 필름 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 신체 보호 제품.
- 제31항에 있어서, 직포가 폴리에스테르, 폴리아미드, 폴리올레핀, 아크릴 수지, 레이욘 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 합성 물질인 신체 보호 제품.
- 제31항에 있어서, 직포가 면, 캠브릭(cambric), 양모, 캐시미어, 황마 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 천연 물질인 신체 보호 제품.
- 제31항에 있어서, 장갑, 양말, 무릎 부목, 발목 부목 및 팔꿈치 부목, 및 성형 패드로 이루어진 그룹으로부터 선택되는 신체 보호 제품.
- 제31항에 있어서, 젤라틴성 물질이 항진균제, 항생제, 방부제, 소염제, 마취제, 침투 향상제, 각질 제거제, 효소, 호르몬, 부식제 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 제3의 약제를 추가로 포함하는 신체 보호 제품.
- 제31항에 있어서, 약 42일간 사용하는 신체 보호 제품.
- 기판을 제공하는 단계(a),비타민 A, B12, C, D, E 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 제1 치료 활성제를 블럭 중합체를 포함하는 젤라틴성 물질 속으로 혼입시키는 단계(b),포도씨 오일, 아보카도 오일, 호호바 오일, 카놀라 오일, 세라마이드, 알로에, 올리브 오일 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 천연 오일인 제2 치료 활성제를 젤라틴성 물질 속으로 혼입시키는 단계(c) 및젤라틴성 물질을 기판에 접착시키는 단계(d)를 포함하는, 신체 보호 제품의 제조방법.
- 제39항에 있어서, 젤라틴성 물질이 SEBS, SEPS, SEEPS 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 방법.
- 제39항에 있어서, 기판이 직포, 종이, 중합체성 필름 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 방법.
- 제39항에 있어서, 신체 보호 기구가 장갑, 양말, 무릎 부목, 발목 부목 및 팔꿈치 부목 및, 성형 패드로 이루어진 그룹으로부터 선택되는 방법.
- 제39항에 있어서, 기판이 면, 캠브릭, 양모, 캐시미어, 레이욘, 황마, 폴리에스테르, 폴리아미드, 폴리올레핀, 아크릴 수지 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 물질의 직포로서 제공되는 방법.
- 제39항에 있어서, 젤라틴성 물질을 가소화 오일과 약 1:2 내지 1:15의 비율로 혼합하는 방법.
- 제39항에 있어서, 젤라틴성 물질을 약 23 내지 약 250℃의 온도에서 가소화 오일, 제1 치료 활성제 및 제2 치료 활성제와 혼합하는 방법.
- 제39항에 있어서, 젤라틴성 물질을 약 23 내지 약 100℃의 제1 온도 범위에서 가소화 오일, 제1 치료 활성제 및 제2 치료 활성제와 혼합하여 페이스트상 혼합물을 형성시킨 다음, 약 150 내지 약 250℃의 제2 온도 범위에서 추가로 가열하는 방법.
- 제39항에 있어서, 젤라틴성 물질에 금속 스테아레이트, 및 지방 아미드와 왁스 중 1종 이상을 혼입시킴으로써 이를 비-접착성이고 비-점착성이며 끈적거리지 않도록 제조하는 방법.
- 제47항에 있어서, 젤라틴성 물질이 항진균제, 항생제, 방부제, 소염제, 마취제, 침투 향상제, 각질 제거제, 효소, 호르몬, 부식제 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 제3의 약제를 추가로 포함하는 방법.
- 제48항에 있어서, 직포가 레이욘, 폴리에스테르, 폴리아미드, 폴리올레핀, 아크릴 수지 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 합성 물질인 방법.
- 제48항에 있어서, 직포가 면, 캠브릭, 양모, 캐시미어, 황마 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 천연 물질인 방법.
- 기판(a),포도씨 오일, 아보카도 오일, 호호바 오일, 카놀라 오일, 세라마이드, 올리브 오일, 알로에 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 천연 오일(b) 및SEBS, SEPS, SEEPS 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 블럭 중합체를 포함하는 젤라틴성 물질(c)을 포함하며, 여기서 천연 오일이 목적하는 신체 부위를 커버하는 형태를 갖는 기판에 접착되어 있는 블럭 공중합체 속에 혼입되어 있는, 신체 보호 제품.
- 기판(a) 및올리브 오일 약 25중량%, 카놀라 오일 약 25중량%, 호호바 오일 약 25중량%, 포도씨 오일 약 12중량%, N-스테아릴 필로스팅고신 대두 추출물 약 10중량%, 비타민 E 약 2중량% 및 잔여량의 불활성 성분이 혼입되어 있는 블럭 중합체(b)를 포함하며, 기판이 목적하는 신체 부위를 커버하는 형태를 갖는, 신체 보호 제품.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/143,282 US6117119A (en) | 1998-08-28 | 1998-08-28 | Gelatinous body protection article having a therapeutic additive |
US09/143,282 | 1998-08-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010079708A KR20010079708A (ko) | 2001-08-22 |
KR100418319B1 true KR100418319B1 (ko) | 2004-02-11 |
Family
ID=22503388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-7002563A Expired - Fee Related KR100418319B1 (ko) | 1998-08-28 | 1999-08-09 | 치료 효과를 갖는 젤라틴성 신체 보호 제품 및 이의 제조방법 |
Country Status (14)
Country | Link |
---|---|
US (2) | US6117119A (ko) |
EP (1) | EP1107812B1 (ko) |
JP (1) | JP2002523193A (ko) |
KR (1) | KR100418319B1 (ko) |
AR (1) | AR024510A1 (ko) |
AT (1) | ATE312642T1 (ko) |
AU (1) | AU743008B2 (ko) |
BR (1) | BR9913313B1 (ko) |
CA (1) | CA2341303C (ko) |
DE (1) | DE69928941T2 (ko) |
DK (1) | DK1107812T3 (ko) |
ES (1) | ES2252961T3 (ko) |
TW (1) | TW478940B (ko) |
WO (1) | WO2000012170A1 (ko) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630152B2 (en) * | 1999-04-07 | 2003-10-07 | Shen Wei (Usa), Inc. | Aloe vera glove and manufacturing method |
US6274154B1 (en) | 1999-04-07 | 2001-08-14 | Belle L Chou | Aloe Vera glove and manufacturing method |
US8529970B2 (en) | 2000-01-03 | 2013-09-10 | International Flora Technologies, Ltd. | High unsaponifiables and methods of using the same |
US20020023283A1 (en) * | 2000-03-31 | 2002-02-28 | Kania Bruce G. | Apparel worn on, in or under the water and a manufacturing method thereof |
FR2809294B1 (fr) | 2000-05-26 | 2002-12-13 | Oreal | Dispositif pour l'application d'un produit cosmetique ou de soin sur les fibres keratiniques, notamment les cils ou les sourcils |
US7806841B2 (en) * | 2000-05-30 | 2010-10-05 | Ronald J Caselnova | Non-ambulatory thermotherapy device for heat and cold therapy of the foot/ankle complex and hand/wrist complex |
BR0112865A (pt) * | 2000-08-04 | 2003-04-22 | Ciba Sc Holding Ag | Processo para o tratamento de materiais têxteis contra fungos e ácaros da poeira |
DE10047708C2 (de) * | 2000-09-25 | 2003-09-18 | Kempe Gmbh | Sensor zur Messung von O¶2¶ Konzentrationen in Flüssigkeiten |
FR2822711B1 (fr) * | 2001-03-28 | 2003-06-13 | Oreal | Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps |
US7244703B2 (en) * | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
DE10130846A1 (de) * | 2001-06-28 | 2003-01-16 | Regeneratio Pharma Ag | Verwendung von Corrinoiden zur Anwendung bei Hauterkrankungen |
US6905487B2 (en) * | 2001-08-27 | 2005-06-14 | Maryann B. Zimmerman | Dermal treatment applicator and method relating thereto |
US6684411B1 (en) * | 2001-08-27 | 2004-02-03 | Edward Bachert | Medical sock |
US7160508B2 (en) * | 2001-09-05 | 2007-01-09 | The Gillette Company | Personal care products having elastomeric portions |
US20030216701A1 (en) * | 2002-05-15 | 2003-11-20 | Gentho Sumarta | Synthetic glove and process for making |
US20050228328A1 (en) * | 2002-08-19 | 2005-10-13 | Carter Linda A | Burn, sunburn, and cellulite treatment system |
WO2004037305A1 (en) * | 2002-10-21 | 2004-05-06 | Allegiance Corporation | Coating composition for skin-contacting surface of elastomeric articles and articles containing the same |
US20040091520A1 (en) * | 2002-11-12 | 2004-05-13 | Samuel Amdur | Disposable gloves with at least one alpha hydroxy acid |
US20040115250A1 (en) * | 2002-12-17 | 2004-06-17 | Ansell Healthcare Products Inc. | Camomile/aloe vera treated glove |
US20040122382A1 (en) * | 2002-12-23 | 2004-06-24 | Kimberly-Clark Worldwide, Inc. | Elastomeric articles with beneficial coating on a surface |
GB0302350D0 (en) * | 2003-02-01 | 2003-03-05 | Allsebrook Brown Ltd | Garments |
EP1635853A4 (en) * | 2003-05-22 | 2008-01-16 | Host Pharmaceuticals Llc | TOPICAL COMPOSITION FOR THE TREATMENT OF SKIN DISEASES AND METHOD OF USE THEREOF |
US20040245670A1 (en) * | 2003-06-03 | 2004-12-09 | Janssen Robert A. | Method of forming a low tack elastomeric article |
US20050031817A1 (en) * | 2003-08-07 | 2005-02-10 | Littleton Kermit R. | Readily donned, powder-free elastomeric article |
US7776368B2 (en) * | 2003-08-13 | 2010-08-17 | Smarthealth, Inc. | Gloves containing dry powdered aloe and method of manufacturing |
US20050081278A1 (en) * | 2003-10-17 | 2005-04-21 | Williams William A. | Polymeric glove with lotion coating and method of making same |
DE602004028284D1 (de) | 2003-12-08 | 2010-09-02 | Cpex Pharmaceuticals Inc | Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung |
US7249385B2 (en) * | 2004-01-20 | 2007-07-31 | Richard Schukraft | Finger/toe tip protective apparatus |
US20050215901A1 (en) | 2004-01-20 | 2005-09-29 | Anderson Thomas L | Interface for use between medical instrumentation and a patient |
US20050228088A1 (en) * | 2004-04-02 | 2005-10-13 | Laghi Aldo A | Precipitation of additives in over-saturated triblock copolymer elastomers |
US20050246821A1 (en) * | 2004-05-05 | 2005-11-10 | Kopp N C | Foot covering |
US8069536B2 (en) * | 2004-06-22 | 2011-12-06 | Willat Ergonomic Technologies, Llc | Conformable pod for a manual implement |
US20060143782A1 (en) * | 2004-10-07 | 2006-07-06 | Sherry Ajluni | Glove with skin lotion |
US20060212997A1 (en) * | 2005-03-08 | 2006-09-28 | Blanchard James C | Footwear covering apparatus |
EP1700895A1 (en) * | 2005-03-11 | 2006-09-13 | National Starch and Chemical Investment Holding Corporation | Peelable hot melt adhesive |
JP4836228B2 (ja) * | 2005-05-11 | 2011-12-14 | 武彦 大浦 | ジェル状の皮膚保護用シート |
US20070026028A1 (en) * | 2005-07-26 | 2007-02-01 | Close Kenneth B | Appliance for delivering a composition |
US20070078413A1 (en) * | 2005-08-25 | 2007-04-05 | Stenzel Eric B | Medical device having a lubricant |
US7269859B2 (en) * | 2006-02-01 | 2007-09-18 | Theresa Wells | Moisture proof glove with a protective cuff |
US20080060118A1 (en) * | 2006-08-28 | 2008-03-13 | Charissa Stuart | Multipurpose open-toed stocking |
US20100095434A1 (en) * | 2006-08-28 | 2010-04-22 | Peeky International Llc | Multipurpose open-toed stocking |
US20080103460A1 (en) * | 2006-10-31 | 2008-05-01 | Close Kenneth B | Method for making an appliance for delivering a composition, the appliance having an elastic layer and a shielding layer |
US20080102093A1 (en) * | 2006-10-31 | 2008-05-01 | Close Kenneth B | Appliance for delivering a composition, the appliance having an elastic layer and a shielding layer |
US20080103461A1 (en) * | 2006-10-31 | 2008-05-01 | Johnson Kroy D | Appliance for delivering a composition, the appliance having an outer fibrous layer and inner liquid-impermeable layer |
US20080116096A1 (en) * | 2006-11-17 | 2008-05-22 | Johnson Kroy D | Liquid-permeable appliance for delivering a composition |
DE102006061186A1 (de) * | 2006-12-22 | 2008-06-26 | Klaus, Anneliese, Dr. | Verwendung von Aluminium- und Chlor-haltigen Verbindungen zur äußerlichen Anwendung bei allergischen Hautreaktionen, Entzündungen, Juckreiz und/oder Schwellungen der Haut |
ITPD20070052A1 (it) * | 2007-02-20 | 2008-08-21 | Luca Carlo De | Calza o calzino rinforzato per il trattamento preventivo e/o terapeutico dell'alluce valgo |
FR2912879B1 (fr) * | 2007-02-22 | 2010-02-26 | Olympia | Dispositif textile de protection corporelle |
US9027166B1 (en) * | 2007-08-14 | 2015-05-12 | Jody Lynn Hagberg | Therapeutic sock system and method |
US20090053273A1 (en) * | 2007-08-21 | 2009-02-26 | Adriana Le | Topical medication garment and system and method for providing topical medication |
ITTO20080412A1 (it) * | 2008-05-29 | 2009-11-30 | Loro Piana S P A | Tessuto ottenuto dalla lavorazione di filati risultanti dalla torsione di fibre animali ritorte con un filamento di seta. |
US20090326622A1 (en) * | 2008-06-26 | 2009-12-31 | Johnson Kroy D | Customizable therapeutic article for applying heat to the body |
WO2010030824A1 (en) * | 2008-09-10 | 2010-03-18 | Silipos, Inc. | Gelatinous elastomer compositions |
FR2941468B1 (fr) | 2009-01-28 | 2011-04-01 | Avelana | Materiau filamenteux ou fibreux impregne de substances actives |
DE102009013843A1 (de) * | 2009-03-18 | 2010-09-23 | MÜLLER, Andreas | Fußbekleidungsstück |
KR101030624B1 (ko) * | 2009-08-13 | 2011-04-20 | 김명환 | 직물용 흡열 조성물을 이용한 흡열 직물의 제조방법 |
WO2011022371A2 (en) | 2009-08-17 | 2011-02-24 | Silipos Inc. | Gel product |
US8580882B1 (en) | 2010-08-12 | 2013-11-12 | Joesph L. Barnes | Glove-forming solution |
US9364029B2 (en) | 2010-10-28 | 2016-06-14 | Hiten Patel | Sock with heel padding and method of making same |
CN102172355A (zh) * | 2011-03-08 | 2011-09-07 | 北京凯宾鸿生物医药科技有限公司 | 一种促进吸收的治疗皮肤疾病药物组合物软膏及其制备方法 |
CN103415223B (zh) * | 2011-03-11 | 2016-08-17 | 安塞尔有限公司 | 具有注塑成型组件的手套 |
US9956387B2 (en) * | 2011-07-08 | 2018-05-01 | Timothy Brown | Article of clothing for applying a pharmaceutical, a pharmaceutical delivery kit and method |
US20140090273A1 (en) * | 2012-09-28 | 2014-04-03 | Sharone Piontkowski | Foot membrane |
CN103370061B (zh) * | 2011-10-17 | 2016-04-13 | 帕拉芬国际有限责任公司 | 皮肤治疗系统 |
WO2014061077A1 (ja) * | 2012-10-15 | 2014-04-24 | 株式会社ベスト工房 | セリシン液を用いた手袋の加工方法 |
US10231497B2 (en) * | 2013-06-10 | 2019-03-19 | Voesh Corporation | Skin care mask glove and mask sock |
EP2944565B1 (en) | 2014-05-13 | 2017-09-27 | Entrotech, Inc. | Erosion protective sleeve |
JP5677611B1 (ja) * | 2014-06-30 | 2015-02-25 | ユニ・チャーム株式会社 | 吸収性物品 |
US20180110274A1 (en) * | 2016-10-26 | 2018-04-26 | Lynell LaRue | Cushioned protective garment and a method for making such |
US20180310651A1 (en) * | 2017-04-27 | 2018-11-01 | Doyle Dianko Boyd, JR. | Therapeutic Energy Patch |
CN108677529A (zh) * | 2018-05-16 | 2018-10-19 | 丁爱军 | 一种纺织品霉试剂及其制备方法和使用方法 |
US12227895B2 (en) * | 2019-12-30 | 2025-02-18 | Microban Products Company | Odor reduction and bacterial control on a textile material |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3384083A (en) * | 1966-02-15 | 1968-05-21 | Cellu Craft Inc | Treatment device |
US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
US3827999A (en) * | 1973-11-09 | 1974-08-06 | Shell Oil Co | Stable elastomeric polymer-oil compositions |
US3896807A (en) * | 1974-06-13 | 1975-07-29 | Gilbert Buchalter | Article impregnated with skin-care formulations |
US5508334A (en) * | 1977-03-17 | 1996-04-16 | Applied Elastomerics, Inc. | Thermoplastic elastomer gelatinous compositions and articles |
US4369284A (en) * | 1977-03-17 | 1983-01-18 | Applied Elastomerics, Incorporated | Thermoplastic elastomer gelatinous compositions |
US5153254A (en) * | 1977-03-17 | 1992-10-06 | Applied Elastomerics, Inc. | Reusable lint remover |
US5262468A (en) * | 1977-03-17 | 1993-11-16 | Applied Elastomerics, Inc. | Thermoplastic elastomer gelatinous compositions |
US4618213A (en) * | 1977-03-17 | 1986-10-21 | Applied Elastomerics, Incorporated | Gelatinous elastomeric optical lens, light pipe, comprising a specific block copolymer and an oil plasticizer |
US5334646B1 (en) * | 1977-03-17 | 1998-09-08 | Applied Elastomerics Inc | Thermoplastic elastomer gelatinous articles |
US5336708A (en) * | 1977-03-17 | 1994-08-09 | Applied Elastomerics, Inc. | Gelatinous elastomer articles |
US5633286B1 (en) * | 1977-03-17 | 2000-10-10 | Applied Elastomerics Inc | Gelatinous elastomer articles |
US4291025A (en) * | 1980-04-11 | 1981-09-22 | Laclede Professional Products, Inc. | Agar gel topical dressing |
DE3103564A1 (de) * | 1981-02-03 | 1982-08-26 | Bayer Ag, 5090 Leverkusen | Gel-polster, verfahren zu deren herstellung und deren verwendung |
US4668224A (en) * | 1983-10-24 | 1987-05-26 | Warner-Lambert Company | Oxidized cellulose as a medical lubricant |
US4622035A (en) * | 1985-01-23 | 1986-11-11 | Betty Palmer | Boot with continuous medicament supply |
US4778786A (en) * | 1985-04-03 | 1988-10-18 | Minnetonka, Inc. | Composition for transdermal drug delivery |
JPS6272611A (ja) * | 1985-09-27 | 1987-04-03 | Kao Corp | 皮膚外用剤 |
US5679399A (en) * | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5549924A (en) * | 1987-07-17 | 1996-08-27 | Robin Renee Thill Shlenker | Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer |
US5497789A (en) * | 1987-07-20 | 1996-03-12 | Zook; Gerald P. | Foot protector incorporating a viscoelastic gel |
US4853978A (en) * | 1987-07-24 | 1989-08-08 | Surgikos, Inc. | Antimicrobial medical glove |
US4867968A (en) * | 1987-12-29 | 1989-09-19 | Florida-Kansas Health Care, Inc. | Elastomeric composition containing therapeutic agents and articles manufactured therefrom |
US5180605A (en) * | 1988-04-23 | 1993-01-19 | Smith & Nephew P.1.C. | Gloves, their manufacture and use |
US4842931A (en) * | 1988-07-19 | 1989-06-27 | Zook Gerald P | Affixable padding material using gelatinous viscoelastic polymer |
US5181914A (en) * | 1988-08-22 | 1993-01-26 | Zook Gerald P | Medicating device for nails and adjacent tissue |
US5167649A (en) * | 1988-08-22 | 1992-12-01 | Zook Gerald P | Drug delivery system for the removal of dermal lesions |
US5098421A (en) * | 1989-10-16 | 1992-03-24 | Zook Gerald P | Viscoelastic gel foot padding and medicating device |
US5336209A (en) * | 1990-04-06 | 1994-08-09 | Porzilli Louis B | Multi-function wound protection bandage and medicant delivery system with simultaneous variable oxygenation |
US5158555A (en) * | 1990-04-06 | 1992-10-27 | Porzilli Louis B | Heal fast wound protection system with perforations |
US5208013A (en) * | 1991-06-03 | 1993-05-04 | Olympus International, Inc. | Composition for skin care and protection |
US5257418A (en) * | 1992-02-07 | 1993-11-02 | Jaskiewicz Eric M | Shock absorbing glove |
US5357636A (en) * | 1992-06-30 | 1994-10-25 | Dresdner Jr Karl P | Flexible protective medical gloves and methods for their use |
US5328449A (en) * | 1992-11-19 | 1994-07-12 | Wells Lamont | Wound dressing for the hands |
US5330452A (en) * | 1993-06-01 | 1994-07-19 | Zook Gerald P | Topical medicating device |
US5489437A (en) * | 1993-08-17 | 1996-02-06 | Applied Extrusion Technologies, Inc. | Hydrogel products and methods of producing same |
US5344406A (en) * | 1993-10-13 | 1994-09-06 | Spooner James J | Method and apparatus for protectively stabilizing and securing an intravenous device |
US5590420A (en) * | 1994-03-24 | 1997-01-07 | Gunn; Robert T. | Low friction apparel |
US5480646A (en) * | 1994-10-12 | 1996-01-02 | Vu; Van N. | Pad for applying medicaments |
US6156024A (en) * | 1996-12-03 | 2000-12-05 | The Procter & Gamble Company | Absorbent articles having lotioned leg cuffs |
US5830237A (en) * | 1996-03-05 | 1998-11-03 | Ohio Willow Wood Company | Gel and cushioning devices |
US5632045A (en) * | 1995-05-08 | 1997-05-27 | Chase Ergonomics, Inc. | Antivibration glove |
US5673437A (en) * | 1995-05-08 | 1997-10-07 | Chase Ergonomics Inc. | Vibration attenuating member and method of making same |
JPH08333252A (ja) * | 1995-06-12 | 1996-12-17 | Sekisui Chem Co Ltd | 皮膚疾患治療用外用剤 |
US5596770A (en) * | 1995-11-01 | 1997-01-28 | Kunesh; J. Denise | Two-ply inflatable sock |
US5919476A (en) * | 1997-09-29 | 1999-07-06 | Pmt Corporation | Reinforced gel sheeting for scar treatment |
TR200001789T2 (tr) * | 1997-10-03 | 2000-10-23 | Lavipharm Laboratories, Inc. | Prolamin-bitki kutuplu lipit kompozisyonu, bunun hazırlama ve uygulama metodu |
US6143946A (en) * | 1998-12-24 | 2000-11-07 | Docter; Joan E. | Therapeutic mat |
-
1998
- 1998-08-28 US US09/143,282 patent/US6117119A/en not_active Expired - Lifetime
-
1999
- 1999-08-09 KR KR10-2001-7002563A patent/KR100418319B1/ko not_active Expired - Fee Related
- 1999-08-09 WO PCT/US1999/018039 patent/WO2000012170A1/en active IP Right Grant
- 1999-08-09 AU AU53957/99A patent/AU743008B2/en not_active Ceased
- 1999-08-09 DK DK99939717T patent/DK1107812T3/da active
- 1999-08-09 JP JP2000567275A patent/JP2002523193A/ja active Pending
- 1999-08-09 CA CA002341303A patent/CA2341303C/en not_active Expired - Fee Related
- 1999-08-09 DE DE69928941T patent/DE69928941T2/de not_active Expired - Lifetime
- 1999-08-09 AT AT99939717T patent/ATE312642T1/de active
- 1999-08-09 ES ES99939717T patent/ES2252961T3/es not_active Expired - Lifetime
- 1999-08-09 EP EP99939717A patent/EP1107812B1/en not_active Expired - Lifetime
- 1999-08-09 BR BRPI9913313-0A patent/BR9913313B1/pt not_active IP Right Cessation
- 1999-08-27 AR ARP990104312A patent/AR024510A1/es unknown
-
2000
- 2000-02-15 TW TW088114715A patent/TW478940B/zh active
- 2000-09-01 US US09/654,581 patent/US6673054B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69928941D1 (de) | 2006-01-19 |
EP1107812A1 (en) | 2001-06-20 |
EP1107812A4 (en) | 2004-05-12 |
ES2252961T3 (es) | 2006-05-16 |
BR9913313A (pt) | 2001-05-22 |
DK1107812T3 (da) | 2006-04-18 |
KR20010079708A (ko) | 2001-08-22 |
EP1107812B1 (en) | 2005-12-14 |
DE69928941T2 (de) | 2006-08-10 |
US6117119A (en) | 2000-09-12 |
AR024510A1 (es) | 2002-10-16 |
CA2341303C (en) | 2007-05-22 |
WO2000012170A1 (en) | 2000-03-09 |
ATE312642T1 (de) | 2005-12-15 |
AU743008B2 (en) | 2002-01-17 |
JP2002523193A (ja) | 2002-07-30 |
CA2341303A1 (en) | 2000-03-09 |
US6673054B1 (en) | 2004-01-06 |
AU5395799A (en) | 2000-03-21 |
BR9913313B1 (pt) | 2008-11-18 |
TW478940B (en) | 2002-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100418319B1 (ko) | 치료 효과를 갖는 젤라틴성 신체 보호 제품 및 이의 제조방법 | |
EP0732108B1 (en) | Structured occlusive dressings | |
US3328259A (en) | Dressing for a wound containing a hemostatic agent and method of treating a wound | |
AU717789B2 (en) | Solid and semi-solid hydrocarbon gels and uses thereof | |
ES2782831T3 (es) | Prenda antideslizante y proceso de fabricación de la misma | |
US20120309850A1 (en) | Wound care device | |
PT1238664E (pt) | Preparações de adesivo | |
JPH03504452A (ja) | 制御放出生物学的活性剤としてポビトンヨウ素を含むポリマー支持体 | |
US11389326B2 (en) | Phase change material for thermal therapy and delivery of active ingredients | |
US20190231598A1 (en) | Phase Change Material For Medical And Cosmetic Applications | |
US20220096805A1 (en) | Skin therapy systems | |
US2616418A (en) | Thermoplastic cast material | |
US6533746B1 (en) | Ankle wrapping system | |
US11707556B2 (en) | Phase change material for thermal therapy and delivery of active ingredients | |
JP6812762B2 (ja) | ゲルエラストマー組成物、及びそれを用いた化粧用ゲルシート | |
JP2000281850A (ja) | ゲルエラストマー組成物 | |
US20190232033A1 (en) | Skin therapy systems | |
KR102542300B1 (ko) | 열가소성 탄성체 겔 조성물을 이용한 2층 구조의 소프트 투명패치 | |
CA3135986C (en) | Skin therapy systems | |
JPH04124128A (ja) | 肛門部疾患治療用貼付剤 | |
WO2022093784A1 (en) | Phase change material for thermal therapy and delivery of active ingredients | |
JPS6026508B2 (ja) | 分散したポリシロキサンを含有する炭化水素ブロツクコポリマ− |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20010227 Patent event code: PA01051R01D Comment text: International Patent Application |
|
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20010328 Comment text: Request for Examination of Application |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20031115 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20040130 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20040202 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20061229 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20080103 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20090107 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20091230 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20101228 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20101228 Start annual number: 8 End annual number: 8 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |